Physician profile
Mandeep Virk
NPI 1760645089
$154,686.01
in general payments reported to CMS, 2019-2025
10 companies · $41K in 2025
The $41K reported for 2025 was more than what 94% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $7,843 · 2021: $24K · 2022: $26K · 2023: $31K · 2024: $9,922 · 2025: $41K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $52K · Travel and Lodging: $25K · Food and Beverage: $4,963.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $52,250.97 |
| Travel and Lodging | $24,625.52 |
| Food and Beverage | $4,963.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exactech, INC. | $150,465.17 | 2019-2025 | |
| Acumed LLC | $1,711.58 | 2019-2020 | |
| Gotham Surgical Solutions & Devices, INC. | $1,200.00 | 2022 | |
| Suvon Surgical LLC | $735.37 | 2024 | |
| Arthrex, INC. | $184.95 | 2024 | |
| Arteriocyte Medical Systems, INC. | $167.06 | 2024 | Magellan |
| Medical Device Business Services, INC. | $150.05 | 2024 | Vivigen Mis Delivery System, Fibergraft Bg Morsels, Fibergraft Aeridyan Matrix |
| Depuy Synthes Sales INC. | $36.67 | 2022 | |
| Horizon Therapeutics Plc | $19.87 | 2020 | |
| Upsher-Smith Laboratories LLC | $15.29 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mandeep Virk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.